Selexipag | compare suppliers & send inquiries for free
Azacus Strategy Consultants Private Limited
MOQ: 5 kg
Looking for Selexipag 475086-01-2?
Here you will find more information about Selexipag. Selexipag was approved by the United States FDA on December 22, 2015 for the treatment of pulmonary arterial hypertension (PAH) to delay disease progression and reduce risk of hospitalization. PAH is a relatively rare disease with usually a poor prognosis requiring more treatment options to prolong long-term outcomes. Marketed by Actelion Pharmaceuticals under brand name Uptravi, selexipag and its active metabolite, ACT-333679 (MRE-269), act as agonists of the prostacyclin receptor to increase vasodilation in the pulmonary circulation and decrease elevated pressure in the blood vessels supplying blood to the lungs.
Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.
Selexipag manufacturers | traders | suppliers
We have 3 companies offering Selexipag from 1 different countries.
Get in contact with the supplier of your choice:
- Azacus Strategy Consultants Private Limited from India
- Honour Lab from India
- Maithri Drugs from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.